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Control of eukaryotic transcription elongation
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Abstract
The Spt4, Spt5, and Spt6 proteins are conserved eukaryotic transcription-elongation factors. Recent
studies have provided the first evidence that they are generally required in multicellular eukaryotes,
including during development and for viral gene expression. 
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It has been clear for over 20 years that the control of tran-
scription elongation is a prominent mechanism of gene regu-
lation  in  prokaryotes.  In  eukaryotes,  although  this  level  of
regulation was clearly demonstrated in 1988 [1], it is mainly
over the past five years that transcription elongation has blos-
somed into a broadly active area of investigation [2,3]. For
example, several recent studies of the human immunodefi-
ciency virus (HIV) Tat protein, a transcriptional activator that
stimulates transcription past a pause site, have helped us to
understand factors required for elongation [4,5]. 
Three transcription-elongation factors that have emerged as
playing critical roles are the Spt4, Spt5, and Spt6 proteins.
These three proteins, conserved among eukaryotes, were ini-
tially discovered by genetic studies in Saccharomyces cere-
visiae  [6].  Further  studies  in  S.  cerevisiae  suggested  that
Spt4, Spt5, and Spt6 are essential for transcription via the
modulation of chromatin structure [7,8]. Spt4 and Spt5 are
tightly associated in a complex, while the physical associa-
tion of the Spt4-Spt5 complex with Spt6 appears to be con-
siderably weaker [9,10]. Evidence over the past two years
has  demonstrated  that  Spt4,  Spt5,  and  Spt6  play  roles  in
transcription elongation in both yeast and humans [9,10],
including a role in activation by Tat [11]. The breadth of the
requirement for these factors in multicellular eukaryotes was
not known, however. Now, four papers [12-15] have illumi-
nated the roles of these factors in vivo. These new studies,
taken  together  with  earlier  work,  portray  Spt4,  Spt5,  and
Spt6 as general transcription-elongation factors, controlling
transcription  both  positively  and  negatively  in  important
regulatory and developmental roles. 
Spt4, Spt5, and Spt6 have characteristics of
general transcription-elongation factors
Two recent studies [12,13] of Spt5 and Spt6 have provided
the first view of their roles in vivo in a multicellular eukary-
ote, in this case Drosophila melanogaster. In both studies,
specific antisera were used to determine the localization of
Spt5  and  Spt6  on  polytene  chromosomes.  Both  studies
demonstrated that Spt5 and Spt6 colocalize to hundreds of
sites  on  polytene  chromosomes  and  that  this  localization
strikingly coincides with that of actively transcribing RNA
polymerase II (Pol II), Pol IIo (Figure 1). This correlation
between  the  Spt  proteins  and  active  transcription  was
strengthened  by  the  demonstration  that  the  induction  of
heat shock (hsp) gene transcription causes massive recruit-
ment of both Spt5 and Spt6 to hsp loci. These results, then,
show  that  Spt5  and  Spt6  are  associated  with  virtually  all
active transcription, strongly suggesting a general positive
role for these factors. 
Evidence  for  a  negative  role,  although  less  general,  came
from  the  colocalization  between  Spt5,  Spt6  and  the  non-
transcribing form of Pol II, Pol IIa, at a small subset of poly-
tene positions [12]. Most of these positions correspond to
the Salivary gland secreted (Sgs) loci, and the colocalization
results  suggest  that  the  Sgs genes  are  regulated  by  Spt5,
Spt6, and perhaps by a transcriptional pause, similar to hsp
genes [12]. In addition, Spt5, but not Spt6, is present at the
uninduced  hsp70 locus,  where  Pol IIa  is  paused  approxi-
mately 25 nucleotides from the initiation site [12,13]. As well
as suggesting a negative role for Spt5, this result indicates
that Spt5 and Spt6 do not play identical roles in vivo. While2 Genome Biology Vol 2 No 2 Winston
the other member of this triad of proteins, Spt4, was not
directly examined in either of these studies [12,13], its strong
physical association with Spt5 suggests that Spt4 is likely to
be similarly localized. These results, suggesting negative as
well as positive control by the Spt proteins in vivo, are con-
sistent with earlier in vitro results [10,16].
In addition to the genome-wide view provided by the poly-
tene  chromosome  studies,  higher-resolution  analysis  has
provided additional insights about Spt5 and Spt6 [13]. Chro-
matin immunoprecipitation analysis revealed that Spt5 and
Spt6 are bound within the open reading frames of heat shock
(hsp) genes after heat shock induction, providing strong evi-
dence for a direct role in transcription elongation. These two
papers  [12,13],  then,  provided  strong  evidence  for  general
roles  for  Spt4,  Spt5,  and  Spt6  in  elongation. In  future
studies,  genetic  analysis  of  Spt4,  Spt5,  and  Spt6  in
D. melanogaster should  provide  important  insights  into
both their positive and negative roles in vivo. 
A role for Spt5 in neuronal development in
zebrafish
An intriguing result emerged from recent studies of foggy, a
zebrafish mutant identified in a screen for mutations that
cause neuronal development defects [14]. The foggy muta-
tion  causes  a  previously  unidentified  pattern  of  neuronal
defect: a reduction of dopamine-containing neurons and a
corresponding increase in serotonin-containing neurons in
the hypothalamus. Positional cloning and sequence analysis
revealed  that  foggy encodes  the  zebrafish  Spt5  homolog.
Thus,  a  mutation  that  impairs  a  transcription-elongation
factor  causes  a  novel  neuronal  developmental  defect.  Bio-
chemical analysis of the mutant Foggy/Spt5 protein demon-
strated a defect in its ability to negatively control elongation
in vitro, suggesting that the foggy mutation allows increased
expression of particular genes in vivo, thereby causing this
specific neuronal defect [14]. Similarly, a developmental role
for Spt6 had been previously suggested on the basis of the
developmental  defects  of  a  Caenorhabditis  elegans spt6
(emb-5) mutant during gastrulation [17].
Studies of the foggy mutant raise the issue of the roles of
general  factors  in  developmental  control.  Is  the  role  of
Foggy/Spt5 in zebrafish dedicated to specific aspects of neu-
ronal  development,  or  does  the  foggy mutant  phenotype
reflect a particular type of defect in a general factor? On the
basis  of  other  studies  of  Spt5,  the  latter  possibility  seems
more likely. The foggy mutation also causes cardiovascular
defects  [18],  indicating  that  this  mutation  is  pleiotropic,
albeit  still  highly  specific  in  the  neuronal  defects  that  it
causes. How might a mutation that alters a general elonga-
tion factor cause specific neuronal defects? One possibility is
that  particular  genes  have  a  stronger  requirement  for
Foggy/Spt5 than do others: a mutation that mildly reduces
Foggy/Spt5  activity  might  affect  a  small  subset  of  genes,
causing  specific  mutant  phenotypes.  Consistent  with  this
idea, reduced levels of Pol II in S. cerevisiae cause specific
mutant  phenotypes  [19].  A  second  possibility  is  that
Foggy/Spt5 interacts with several gene-specific transcription
factors and the foggy mutation impairs only an interaction
between Spt5 and a neuronal-specific transcription factor.
This idea is supported by the demonstration of allele-specific
phenotypes among different  spt5 mutants in  S. cerevisiae
[9]. Allele-specific developmental defects have been identi-
fied  for  mutants  of  general  factors,  including  Pol II  (for
examples, see [20,21]). It would be of great interest to iden-
tify additional foggy alleles and study their effect on neu-
ronal  development.  The  identification  of  proteins  that
interact  with  Foggy/Spt5  might  identify  neuron-specific
transcription-elongation factors. 
Human cytomegalovirus and Spt6
The  fourth  recent  study  [15]  concerns  the  human
cytomegalovirus (CMV) activator pUL69. This regulator is
required for transcription of several CMV genes [22] and is
also  responsible  for  arresting  CMV-infected  cells  in  G1
phase of the cell cycle [23]. To learn more about the func-
tion  of  pUL69,  a  two-hybrid  protein-protein  interaction
screen was performed to identify pUL69-interacting pro-
teins, and human Spt6 was identified. Additional experi-
ments  provide  compelling  evidence  that  pUL69  is
physically associated with Spt6 in CMV-infected cells. The
biological relevance of this interaction was established by
the  complete  correlation  between  pUL69  mutations  that
impair interaction with Spt6 and those that impair pUL69-
dependent transcriptional activation. 
How might an interaction with Spt6 help explain transcrip-
tional activation by pUL69? One model comes from experi-
ments  that  addressed  the  interaction  of  human  Spt6  with
histones. Previous studies of yeast Spt6 had demonstrated
Figure 1
Colocalization of (a) Spt5 and (b) Spt6 with Pol IIoser2
(Pol IIo phosphorylated on Ser2) on Drosophila polytene
chromosomes. Spt5 and Spt6 are red, Pol IIoser2 is green and
colocalization is shown as yellow. Polytene positions 74EF
and 75B are indicated. Adapted with permission from [12].c
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an Spt-histone interaction in vitro [8]. In the current study
[15], the authors have demonstrated a human Spt6-histone
H3 interaction and show that this interaction is antagonized
by pUL69. These results suggest that activation by pUL69
occurs by overcoming the repression of transcription caused
by an Spt6-histone interaction. Of interest with respect to
the models discussed above for the effects of Foggy/Spt5 in
the zebrafish, this work demonstrates that Spt6 specifically
interacts with a particular transcriptional activator. Earlier
work  suggested  that  Spt6  also  interacts  with  the  estrogen
receptor [24]. Spt6 may, therefore, interact with many gene-
specific transcription factors. The pUL69 studies also raise
interesting and related issues. First, does the pUL69-Spt6
interaction serve to control transcription initiation or elon-
gation? Second, what directs the association of Spt6 with the
CMV genome after infection? Third, does Spt6 play a role in
all  pUL69-dependent  transcription?  Finally,  do  Spt4  and
Spt5 also play a role in pUL69 activation? The answers to
these questions will undoubtedly teach us more about Spt4,
Spt5, and Spt6.
The recent studies discussed in this article portray Spt4, Spt5,
and Spt6 as general elongation factors that are likely to have
many interactions with other factors in vivo, including Pol II,
histones,  and  gene-specific  transcription  factors.  Future
studies  will  need  to  address  the  distinctions  between  their
positive and negative roles, the individual roles of Spt4, Spt5,
and Spt6, and their possible regulation during development. 
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